HuGE Literature Finder
Records
1
-
30
| Treatment Patterns and Survival of Patients With Advanced Non-Small Cell Lung Cancer Guided by Comprehensive Genomic Profiling: Real-World Single-Institute Study in China. Frontiers in oncology 2021 11 630717. Lv Weize, Cheng Hua, Shao Di, Wei Yajun, Zhu Weiping, Wu Kui, Jiang Wenxi, Hu Liyang, Sha Zhou, Zhong Beilong, Pei Xiaofe |
| Kirsten rat sarcoma virus protein overexpression in adenocarcinoma lung: Association with clinicopathological and histomorphological features. Journal of carcinogenesis 2020 19 9. Pandey Rahul Kumar, Shukla Saumya, Hadi Rahat, Husain Nuzhat, Islam Mohammad Hayatul, Singhal Ashish, Tripathi Surya Kant, Garg Raj |
| Programmed cell death ligand 1 expression in cytologic and surgical non-small cell lung carcinoma specimens from a single institution: Association with clinicopathologic features and molecular alterations. Cancer cytopathology 2019 Apr . Mei Ping, Shilo Konstantin, Wei Lai, Shen Rulong, Tonkovich Dena, Li Zai |
| Frequency of Somatic TP53 Mutations in Combination with Known Pathogenic Mutations in Colon Adenocarcinoma, Non-Small Cell Lung Carcinoma, and Gliomas as Identified by Next-Generation Sequencing. Neoplasia (New York, N.Y.) 2018 Feb 20 (3): 256-262. Shajani-Yi Zahra, de Abreu Francine B, Peterson Jason D, Tsongalis Gregory |
| KRAS mutation is predictive of outcome in patients with pulmonary sarcomatoid carcinoma. Histopathology 2018 Feb . Mehrad Mitra, Roy Somak, LaFramboise William A, Petrosko Patti, Miller Caitlyn, Incharoen Pimpin, Dacic San |
| RASA1 and NF1 are Preferentially Co-Mutated and Define A Distinct Genetic Subset of Smoking-Associated Non-Small Cell Lung Carcinomas Sensitive to MEK Inhibition. Clinical cancer research : an official journal of the American Association for Cancer Research 2017 Nov . Hayashi Takuo, Desmeules Patrice, Smith Roger S, Drilon Alexander, Somwar Romel, Ladanyi Ma |
| Correlation between molecular analysis, diagnosis according to the 2015 WHO classification of unresected lung tumours and TTF1 expression in small biopsies and cytology specimens from 344 non-small cell lung carcinoma patients. Pathology 2017 Aug . Russell Prudence A, Rogers Toni-Maree, Solomon Benjamin, Alam Naveed, Barnett Stephen A, Rathi Vivek, Williams Richard A, Wright Gavin M, Conron Matth |
| Relationship between driver gene mutations, their relative protein expressions and survival in non-small cell lung carcinoma in Macao. The clinical respiratory journal 2017 Jul . Chan Kin Iong, Vong Hong Ting, Sin Lai Fang, Yip Yuk Ching, Zhong Xue Yun, Wen Jian Mi |
| Comprehensive profiling and quantitation of oncogenic mutations in non-small cell lung carcinoma using single-molecule amplification and re-sequencing technology. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2017 Feb 39 (2): 1010428317691413. Shi Jian, Yuan Meng, Wang Zhan-Dong, Xu Xiao-Li, Hong Lei, Sun Shengl |
| Comprehensive profiling and quantitation of oncogenic mutations in non small-cell lung carcinoma using single molecule amplification and re-sequencing technology. Oncotarget 2016 Jul . Zhang Shirong, Xia Bing, Jiang Hong, Wang Limin, Xu Rujun, Shi Yanbin, Zhang Jianguang, Xu Mengnan, Cram David S, Ma Shengl |
| Limits and potential of targeted sequencing analysis of liquid biopsy in patients with lung and colon carcinoma. Oncotarget 2016 Jul . Rachiglio Anna Maria, Abate Riziero Esposito, Sacco Alessandra, Pasquale Raffaella, Fenizia Francesca, Lambiase Matilde, Morabito Alessandro, Montanino Agnese, Rocco Gaetano, Romano Carmen, Nappi Anna, Iaffaioli R Vincenzo, Tatangelo Fabiana, Botti Gerardo, Ciardiello Fortunato, Maiello Monica R, De Luca Antonella, Normanno Nico |
| Morphological and molecular approach to synchronous non-small cell lung carcinomas: impact on staging. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2016 Apr . Schneider Frank, Derrick Veronica, Davison Jon M, Strollo Diane, Incharoen Pimpin, Dacic San |
| Detection of PIK3CA mutations, including a novel mutation of V344G in exon 4, in metastatic lung adenocarcinomas: A retrospective study of 115 FNA cases. Cancer cytopathology 2016 Mar . Allison Derek B, Lilo Mohammed T, Geddes Susan, Pallavajjalla Aparna, Askin Frederic, Gabrielson Edward, Zheng Gang, Li Qing K |
| MET Amplification and Exon 14 Splice Site Mutation Define Unique Molecular Subgroups of Non-Small Cell Lung Carcinoma with Poor Prognosis. Clinical cancer research : an official journal of the American Association for Cancer Research 2016 Feb . Tong Joanna H, Yeung Sai F, Chan Anthony Wh, Chung Lau Y, Chau Shuk L, Lung Raymond Wai Ming, Tong Carol Y, Chow Chit, Tin Edith Ky, Yu Yau H, Li Hui, Pan Yi, Chak Wing P, Ng Calvin Sh, Mok Tony S K, To Ka |
| Molecular spectrum of somatic EGFR and KRAS gene mutations in non small cell lung carcinoma: determination of frequency, distribution pattern and identification of novel variations in Indian patients. Pathology oncology research : POR 2015 Jul 21 (3): 675-87. Das Bibhu Ranjan, Bhaumik Sangeet, Ahmad Firoz, Mandsaurwala Aziz, Satam Hee |
| Association of CCND1 overexpression with KRAS and PTEN alterations in specific subtypes of non-small cell lung carcinoma and its influence on patients' outcome. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2015 Jun . Dragoj Miodrag, Milosevic Zorica, Bankovic Jasna, Dinic Jelena, Pesic Milica, Tanic Nikola, Stankovic Tija |
| [Clinical Research of EGFR and KRAS Mutation in Fine Needle Aspiration Cytology Specimens of Non-small Cell Lung Carcinoma]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 2015 Apr 18 (4): 199-205. Zhang Zhihui, Wu Xilan, Ying Jianming, Li Junling, Qiu Tian, Guo Huiqin, Zhao Huan, Shan Ling, Ling Y |
| Outcomes by tumor histology and KRAS mutation status after lung stereotactic body radiation therapy for early-stage non-small-cell lung cancer. Clinical lung cancer 2015 Jan 16 (1): 24-32. Mak Raymond H, Hermann Gretchen, Lewis John H, Aerts Hugo J W L, Baldini Elizabeth H, Chen Aileen B, Colson Yolonda L, Hacker Fred H, Kozono David, Wee Jon O, Chen Yu-Hui, Catalano Paul J, Wong Kwok-Kin, Sher David |
| Alterations of LKB1 and KRAS and risk of brain metastasis: comprehensive characterization by mutation analysis, copy number, and gene expression in non-small-cell lung carcinoma. Lung cancer (Amsterdam, Netherlands) 2014 Nov 86 (2): 255-61. Zhao Ni, Wilkerson Matthew D, Shah Usman, Yin Xiaoying, Wang Anyou, Hayward Michele C, Roberts Patrick, Lee Carrie B, Parsons Alden M, Thorne Leigh B, Haithcock Benjamin E, Grilley-Olson Juneko E, Stinchcombe Thomas E, Funkhouser William K, Wong Kwok-Kin, Sharpless Norman E, Hayes D Ne |
| Increased NQO1 but not c-MET and survivin expression in non-small cell lung carcinoma with KRAS mutations. International journal of environmental research and public health 2014 Sep 11 (9): 9491-502. Yilmaz Ahmet, Mohamed Nehad, Patterson Kara A, Tang Yan, Shilo Konstantin, Villalona-Calero Miguel A, Davis Michael E, Zhou Xiaoping, Frankel Wendy, Otterson Gregory A, Beall Howard D, Zhao Weiqia |
| Performance evaluation comparison of 3 commercially available PCR-based KRAS mutation testing platforms. Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 2014 Mar 22 (3): 231-5. Adams Julia A, Post Kristin M, Bilbo Sarah A, Wang Xiaoyan, Sen Joyashree D, Cornwell Anita J, Malek Amanda J, Cheng Lia |
| Mutated ephrin receptor genes in non-small cell lung carcinoma and their occurrence with driver mutations-targeted resequencing study on formalin-fixed, paraffin-embedded tumor material of 81 patients. Genes, chromosomes & cancer 2013 Dec 52 (12): 1141-9. Mäki-Nevala Satu, Kaur Sarhadi Virinder, Tuononen Katja, Lagström Sonja, Ellonen Pekka, Rönty Mikko, Wirtanen Aino, Knuuttila Aija, Knuutila Saka |
| Diagnostic value of immunohistochemistry for the detection of the BRAFV600E mutation in primary lung adenocarcinoma Caucasian patients. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2013 Mar 24 (3): 742-8. Ilie M, Long E, Hofman V, Dadone B, Marquette C H, Mouroux J, Vignaud J M, Begueret H, Merlio J P, Capper D, von Deimling A, Emile J F, Hofman |
| Comparison of targeted next-generation sequencing (NGS) and real-time PCR in the detection of EGFR, KRAS, and BRAF mutations on formalin-fixed, paraffin-embedded tumor material of non-small cell lung carcinoma-superiority of NGS. Genes, chromosomes & cancer 2013 Jan . Tuononen K, Mäki-Nevala S, Sarhadi VK, Wirtanen A, Rönty M, Salmenkivi K, Andrews JM, Telaranta-Keerie AI, Hannula S, Lagström S, Ellonen P, Knuuttila A, Knuutila S |
| Screening for EGFR and KRAS mutations in non-small cell lung carcinomas using DNA extraction by hydrothermal pressure coupled with PCR-based direct sequencing. International journal of clinical and experimental pathology 2013 6 (9): 1880-9. Liu Yan, Wu Bing-Quan, Zhong Hao-Hao, Hui Pei, Fang Wei-Ga |
| The frequency of EGFR and KRAS mutations in non-small cell lung cancer (NSCLC): routine screening data for central Europe from a cohort study. BMJ open 2013 3 (4): 4. Boch Christian, Kollmeier Jens, Roth Andreas, Stephan-Falkenau Susann, Misch Daniel, Grüning Wolfram, Bauer Torsten Thomas, Mairinger Thom |
| Impact of systematic EGFR and KRAS mutation evaluation on progression-free survival and overall survival in patients with advanced non-small-cell lung cancer treated by erlotinib in a French prospective cohort (ERMETIC project--part 2). Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2012 Oct 7 (10): 1490-502. Cadranel Jacques, Mauguen Audrey, Faller Michele, Zalcman Gérard, Buisine Marie-Pierre, Westeel Virginie, Longchampt Elisabeth, Wislez Marie, Coudert Bruno, Daniel Catherine, Chetaille Bruno, Michiels Stephane, Blons Helene, Solassol Jerome, De Fraipont Florence, Foucher Pascal, Urban Thierry, Lacroix Ludovic, Poulot Virginie, Quoix Elisabeth, Antoine Martine, Danton Guillaume, Morin Franck, Chouaid Christos, Pignon Jean-Pier |
| Inverse correlation between EGFR mutation and FHIT, RASSF1A and RUNX3 methylation in lung adenocarcinoma: relation with smoking status. Anticancer research 2011 Apr 31 (4): 1211-4. Yanagawa Naoki, Tamura Gen, Oizumi Hiroyuki, Endoh Makoto, Sadahiro Mitsuaki, Motoyama Teiic |
| Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression. Molecular cancer 2010 9 (1): 188. Zhang Xuchao, Zhang Shirley, Yang Xuening, Yang Jinji, Zhou Qing, Yin Lucy, An Shejuan, Lin Jiaying, Chen Shiliang, Xie Zhi, Zhu Mike, Zhang Xiaolin, Wu Yi-lo |
| Genome wide SNP comparative analysis between EGFR and KRAS mutated NSCLC and characterization of two models of oncogenic cooperation in non-small cell lung carcinoma. BMC medical genomics 2008 Jun 1 (1): 25. Blons H, Pallier K, Le Corre D, Danel C, Tremblay M, Houdayer C, Fabre-Guillevin E, Riquet M, Dessen P, Laurent-Puig P |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jan 20, 2022
- Content source: